Newsroom
Truveta news releases
Partnership news: Truveta and Mathematica to advance public health and health equity with real-world data
Powerful partnership will allow researchers access to the most complete, timely, and clean health data to improve outcomes BELLEVUE, Wash. and PRINCETON, New Jersey – September 21, 2023 – Truveta, a leading EHR data and analytics company, and Mathematica, a policy...
Medical Components Inc. and Truveta partner to advance care for patients living with cancer and chronic kidney disease
Truveta Data will enable Medical Components, Inc. to study manufacturer-specific medical device data to address medical evidence gaps and improve clinical care recommendations. BELLEVUE, Wash. – September 12, 2023 – Medical Components, Inc. is partnering with Truveta...
Truveta Data now includes medication dispense data to help address nation’s 7th leading cause of death
With new medication dispense data – including prescription fill data from specialty pharmacies – Truveta Data offers even more complete, timely, and clean data to study patient care and outcomes. BELLEVUE, Wash. – August 8, 2023 – Today Truveta announced the addition...
Truveta community expands to more than 40 healthcare and life science organizations with a shared mission of saving lives with data
BELLEVUE, Wash. – May 17, 2023 – Today Truveta, a leader in electronic health record (EHR) data and analytics, announces the expansion of its community to include new life science partners, including Reprieve Cardiovascular and SK Life Science, joining previously...
Truveta collaboration with Harvard University researchers published in JAMA Network Open
New research published in JAMA Network Open shows changes in minoxidil prescribing following media attention about oral use for hair loss. BELLEVUE, Wash. – May 11, 2023 – Today Truveta announced a new research letter published in JAMA Network Open using de-identified...
Truveta Language Model unlocks EHR data for the most complete and accurate medical research
Truveta’s clinical expert-led AI delivers the cleanest healthcare data, including structured concepts from clinician notes BELLEVUE, Wash. – April 12, 2023 – Today Truveta introduces the Truveta Language Model (TLM), a large-language, multi-modal AI model for...
Truveta and Alpine Immune Sciences announce strategic partnership to access Truveta’s community to accelerate recruitment to povetacicept clinical trials
Truveta’s 28 health system members provide over 16% of patient care in the United States. BELLEVUE and SEATTLE, Wash. – March 21, 2023 – Today, Truveta and Alpine Immune Sciences, Inc. (NASDAQ: ALPN) announced a strategic partnership to help accelerate clinical trial...
New SDOH data in Truveta Studio provide most complete view of health equity’s influence on patient health and outcomes
Expanded de-identified social drivers of health data in Truveta Studio empower new health equity scenarios to study health disparities and improve patient care. BELLEVUE, Wash. – February 28, 2023 – Truveta announced the expansion of its de-identified data to include...
Truveta’s COVID-19 breakthrough infections research published in Vaccine
In a study of more than 1.2 million patients, new research shows the interaction effects of multiple comorbidities on the increased risk of COVID-19 breakthrough infections and hospitalizations. BELLEVUE, Wash. – February 23, 2023 – Today Truveta announced new...
